OneMedNet Corporation ONMD

0.65 (0.06) (8.45%) as of 25 Sep
Market cap
$41.8M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '21 Jan '21 Dec '17
P/E ratio
0.00 0.00 0.00 0.00 — — — —
P/S ratio
36.06 59.39 5.27 0.00 — — — —
P/FCF ratio
0.00 0.00 0.00 0.00 — — — —
P/Operating CF
(28.61) (19.13) (3.12) (10.62) — — — —
P/B ratio
0.00 0.00 0.00 0.00 — — — —
Price to Tangible BV
0.00 0.00 0.00 0.00 — — — —
EV/Sales
35.97 63.06 9.07 0.00 — — — —
EV/EBITDA
0.00 0.00 0.00 0.00 — — — —
EV/Operating CF
(6.52) (5.83) (1.93) (9.08) — — — —
EV/FCF
(6.50) (5.79) (1.89) (9.08) — — — —
Quick Ratio
0.33 0.17 0.01 0.01 0.02 1.56 1.56 —
Current Ratio
0.43 0.19 0.03 0.02 0.02 1.85 1.85 —
Net Debt/EBITDA
0.01 (0.06) (0.50) (0.16) 0.01 0.77 0.77 —
Debt/Assets
45.28% 96.81% 745.04% 116.37% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
(0.33) (0.23) (0.26) (0.06) 0.00 0.00 0.00 —
Asset Turnover
0.46 0.31 1.16 0.08 0.00 0.00 0.00 —
Operating CF/Net income
2.68 0.69 0.14 0.15 (2.79) (0.07) (0.07) —
Capex/Depreciation
(0.20) (0.89) (1.57) (2.32) — — — —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
ROE
29.62% 68.92% 117.61% 253.13% 5.94% 10.26% 10.26% —
ROA
(95.30%) (483.37%) (3,853.96%) (200.67%) 0.46% 4.36% 8.72% —
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Return on Tangible Assets
104.75% 65.34% 252.58% 118.81% (17.31%) 2,086.03% 2,086.03% —
Average Days of Receivables
132.95 120.91 54.34 6.01 — — — —
Research and Development Expense of Revenue
111.48% 228.15% 202.25% 137.99% — — — —
Selling, General and Administrative Expense of Revenue
562.84% 1,221.93% 456.32% 499.91% 0.00% — 0.00% —
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
149.52% 97.67% 144.47% 161.75% — — — —
Graham Net Nets
(0.06) (0.42) (2.52) (0.66) — — — —
Graham Number
0.33 2.15 13.90 44.30 — — — —
Earnings Yield
(6.74%) (26.47%) (627.82%) (75.45%) — — — —
Free Cash Flow Yield
(15.34%) (18.34%) (90.94%) (11.34%) — — — —
Revenue per Share
0.03 0.02 0.14 0.29 0.00 0.00 0.00 —
Operating CF per Share
(0.17) (0.25) (0.66) (1.18) (0.08) (0.11) (0.03) —
Capex per Share
0.00 0.00 (0.01) (0.01) 0.00 0.00 0.00 —
Free Cash Flow per Share
(0.17) (0.25) (0.66) (1.20) (0.08) (0.11) (0.03) —
Cash per Share
0.02 0.11 0.01 0.07 0.00 0.14 0.03 —
Shareholders Equity per Share
(0.07) (0.57) (1.85) (6.63) 1.64 (2.61) 7.27 —
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Book value per Share
(0.07) (0.57) (1.85) (6.63) 1.64 (2.61) 7.27 —
Free Cash Flow
(7.52) (7.00) (4.83) (4.76) (0.94) (0.38) (0.38) —
Working Capital
(2.73) (15.61) (13.47) (25.71) (1.95) 0.25 0.25 —
Capital Expenditures
(0.01) (0.05) (0.04) (0.06) — — — —
Net Current Asset Value
(3.02) (16.06) (13.54) (27.26) (9.09) (125.93) (8.63) —
EV/EBIT
0.00 0.00 0.00 0.00 — — — —
Capex to Sales
0.01 0.08 0.04 0.05 — — — —
Net Profit Margin
(206.11%) (1,575.27%) (3,308.52%) (2,641.02%) 0.00% 0.00% 0.00% —
Price to Operating Income
0.00 0.00 0.00 0.00 — — — —
Other line items
Depreciation/Fixed assets
1.16 0.53 0.28 0.30 — — — —
Cash ROIC
839.89% 75.74% 49.21% 19.46% (4.71%) 4.64% (0.35%) —
Accounts Receivable Turnover
3.84 3.52 11.94 0.00 — — — —
Accounts Payable Turnover
0.39 0.17 0.39 0.00 — — — —
Inventory Turnover
0.00 0.00 0.00 0.00 — — — —
Average Days of Payables
685.31 2,385.14 1,486.03 283.94 — — — —
Days of Inventory on Hand
0.00 0.00 0.00 0.00 — — — —
Average Receivables
0.35 0.18 0.09 — — — — —
Average Payables
4.77 5.36 2.93 — — — — —
Average Assets
2.94 2.10 0.88 15.17 73.46 117.86 58.93 —
Average Common Equity
(9.46) (14.70) (28.72) (12.03) 5.67 50.04 50.04 —

Fold the line items

Columns are period end dates